NYSE:NNVC
NanoViricides, Inc Stock News
$1.18
+0.0150 (+1.29%)
At Close: Apr 18, 2024
NanoViricides to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit Today, July 21, 2020
10:15am, Tuesday, 21'st Jul 2020
SHELTON, CT / ACCESSWIRE / July 21, 2020 / NanoViricides, Inc.
SAN FRANCISCO, July 20, 2020 -- Hagens Berman urges investors in NanoViricides, Inc. (NNVC) to submit their losses now. The firm is investigating possible securities fraud, and.
Glancy Prongay & Murray LLP, a National Class Action Law Firm, Announces Investigation of NanoViricides, Inc. (NNVC) on Behalf of Investors
PHILADELPHIA, July 16, 2020 -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of NanoViricides, Inc. (“NanoViricides” or the.
Glancy Prongay & Murray LLP, a National Class Action Law Firm, Announces Investigation of NanoViricides, Inc. (NNVC) on Behalf of Investors
Cashing in on coronavirus: Small biopharma company NanoViricides sees stock soar on treatment claims
11:00am, Tuesday, 14'th Jul 2020
As the coronavirus was spreading in China, a small biopharma company, NanoViricides, claimed it was close to clinical trials for a treatment. A CNBC investigation found the 15-year-old company has nev
NanoViricides Closes On $11.5 Million Underwritten Public Offering of Common Stock
10:30am, Monday, 13'th Jul 2020
SHELTON, CT / ACCESSWIRE / July 13, 2020 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomed
NanoViricides Prices $10.0 Million Underwritten Public Offering of Common Stock
10:15am, Thursday, 09'th Jul 2020
SHELTON, CT / ACCESSWIRE / July 9, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines pl
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
12:00am, Thursday, 09'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 8)
Akero Therapeutics Inc (...
Nanoviricides Commences Underwritten Public Offering of Common Stock
09:55pm, Wednesday, 08'th Jul 2020
SHELTON, CT / ACCESSWIRE / July 8, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines pl
Covid-19 Research Update: The Stars and the Question Marks
09:50pm, Wednesday, 08'th Jul 2020
While giants like Gilead Sciences and Pfizer are progressing well, many small players have witnessed setbacks in their Covid-19 research Continue reading...
SHELTON, CT / ACCESSWIRE / July 8, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines pl
NanoViricides Announces Addition to Russell Microcap(R) Index
10:15am, Tuesday, 30'th Jun 2020
SHELTON, CT / ACCESSWIRE / June 30, 2020 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines
Covid-Linked Stocks Rally on Trump’s ‘Surprise’ Hint, Day Trades - BNN Bloomberg
05:14pm, Thursday, 25'th Jun 2020
Drug and vaccine makers working on Covid-19 medicines rallied after President Donald Trump hinted at a “big surprise” coming soon, while day traders continued to favor a handful of smaller develop
NanoViricides: Sufficient Funding for Covid-19 Research
03:05pm, Thursday, 25'th Jun 2020
After two successful rounds of fundraising in 2020, the company has adequate cash to move forward Continue reading...
